Up-regulation of ephrin-A1 during melanoma progression

Int J Cancer. 1999 Oct 22;84(5):494-501. doi: 10.1002/(sici)1097-0215(19991022)84:5<494::aid-ijc8>3.0.co;2-o.


Ephrin-A1, formerly called B61, is a new melanoma growth factor; it is angiogenic and chemoattractant for endothelial cells. EPH-A2, or ECK (a receptor for ephrin-A1), is ectopically expressed in most melanoma cell lines; the pathology where this expression is first manifested and the possible role of the receptor in tumor progression are unknown. To determine these, we studied the expression of this ligand and receptor in biopsies of benign and malignant melanocytic lesions. EPH-A2 was not detected in normal melanocytes, benign compound nevi or advanced melanomas, though it was found in 2 of 9 biopsies of malignant melanoma in situ. Ephrin-A1 was present in occasional early lesions and in advanced primary melanomas (43%) and metastatic melanomas (67%). Expression of ephrin-A1 was induced in melanoma cells by pro-inflammatory cytokines. Our findings are consistent with 2 possible roles for ephrin-A1 in melanoma development: it may promote melanocytic cell growth or survival and induce vascularization in advanced melanomas. Both effects may be potentiated by inflammatory responses. Our data are consistent with earlier observations that an inflammatory infiltrate is associated with poor prognosis in thin primary melanomas.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cytokines / pharmacology
  • Ephrin-A1
  • Humans
  • Immunohistochemistry
  • Melanoma / metabolism*
  • Melanoma / pathology
  • Membrane Proteins / analysis
  • Membrane Proteins / biosynthesis
  • Membrane Proteins / genetics
  • Protein Biosynthesis*
  • Proteins / analysis
  • Proteins / genetics
  • RNA, Messenger / analysis
  • Receptor, EphA2
  • Tumor Cells, Cultured
  • Up-Regulation


  • Cytokines
  • Ephrin-A1
  • Membrane Proteins
  • Proteins
  • RNA, Messenger
  • Receptor, EphA2